Combined Hormone Replacement Therapy Increases Risk Of Lobular…
Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new…
No comments:
Post a Comment